Brattsand M - Search Results

1

Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif.

Chen X, Riley BT, de Veer SJ, Hoke DE, Van Haeften J, Leahy D, Swedberg JE, Brattsand M, Hartfield PJ, Buckle AM, Harris JM. Chen X, et al. Among authors: brattsand m. PLoS One. 2019 Jan 22;14(1):e0210842. doi: 10.1371/journal.pone.0210842. eCollection 2019. PLoS One. 2019. PMID: 30668585 Free PMC article.

2

Engineered protease inhibitors based on sunflower trypsin inhibitor-1 (SFTI-1) provide insights into the role of sequence and conformation in Laskowski mechanism inhibition.

de Veer SJ, Swedberg JE, Akcan M, Rosengren KJ, Brattsand M, Craik DJ, Harris JM. de Veer SJ, et al. Among authors: brattsand m. Biochem J. 2015 Jul 15;469(2):243-53. doi: 10.1042/BJ20150412. Epub 2015 May 18. Biochem J. 2015. PMID: 25981970

3

Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors.

de Veer SJ, Swedberg JE, Brattsand M, Clements JA, Harris JM. de Veer SJ, et al. Among authors: brattsand m. Biol Chem. 2016 Dec 1;397(12):1237-1249. doi: 10.1515/hsz-2016-0112. Biol Chem. 2016. PMID: 26894578

4

Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum.

de Veer SJ, Furio L, Swedberg JE, Munro CA, Brattsand M, Clements JA, Hovnanian A, Harris JM. de Veer SJ, et al. Among authors: brattsand m. J Invest Dermatol. 2017 Feb;137(2):430-439. doi: 10.1016/j.jid.2016.09.017. Epub 2016 Sep 30. J Invest Dermatol. 2017. PMID: 27697464 Free article.

5

A Versatile and Robust Serine Protease Inhibitor Scaffold from Actinia tenebrosa.

Chen X, Leahy D, Van Haeften J, Hartfield P, Prentis PJ, van der Burg CA, Surm JM, Pavasovic A, Madio B, Hamilton BR, King GF, Undheim EAB, Brattsand M, Harris JM. Chen X, et al. Among authors: brattsand m. Mar Drugs. 2019 Dec 12;17(12):701. doi: 10.3390/md17120701. Mar Drugs. 2019. PMID: 31842369 Free PMC article.

6

Characterization of SPINK9, a KLK5-specific inhibitor expressed in palmo-plantar epidermis.

Brännström K, Ohman A, von Pawel Rammingen U, Olofsson A, Brattsand M. Brännström K, et al. Among authors: brattsand m. Biol Chem. 2012 Apr;393(5):369-77. doi: 10.1515/hsz-2011-0238. Biol Chem. 2012. PMID: 22505519

7

SPINK9: a selective, skin-specific Kazal-type serine protease inhibitor.

Brattsand M, Stefansson K, Hubiche T, Nilsson SK, Egelrud T. Brattsand M, et al. J Invest Dermatol. 2009 Jul;129(7):1656-65. doi: 10.1038/jid.2008.448. Epub 2009 Feb 5. J Invest Dermatol. 2009. PMID: 19194479 Free article.

8

Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation.

Brattsand M, Egelrud T. Brattsand M, et al. J Biol Chem. 1999 Oct 15;274(42):30033-40. doi: 10.1074/jbc.274.42.30033. J Biol Chem. 1999. PMID: 10514489 Free article.

9

hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.

Egelrud T, Brattsand M, Kreutzmann P, Walden M, Vitzithum K, Marx UC, Forssmann WG, Mägert HJ. Egelrud T, et al. Among authors: brattsand m. Br J Dermatol. 2005 Dec;153(6):1200-3. doi: 10.1111/j.1365-2133.2005.06834.x. Br J Dermatol. 2005. PMID: 16307658

10

Molecular cloning and tissue expression of the murine analog to human stratum corneum chymotryptic enzyme.

Bäckman A, Strandén P, Brattsand M, Hansson L, Egelrud T. Bäckman A, et al. Among authors: brattsand m. J Invest Dermatol. 1999 Aug;113(2):152-5. doi: 10.1046/j.1523-1747.1999.00662.x. J Invest Dermatol. 1999. PMID: 10469296 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters